Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Oncology
Study Phase : Phase IV
Recipient : UT Southwestern Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 27, 2016
Lead Product(s) : Levothyroxine Sodium
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Recipient : UT Southwestern Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable